Elevated levels of inflammatory cytokines, C-reactive protein (CRP), and homocysteine in IBD contribute to vascular injury and atherogenesis, while gut microbiota dysbiosis and increased coagulation factors may further predispose patients to arterial thromboembolic events, independent of traditional cardiovascular risk factors [7,8]. Here, CRP is linked to inflammatory bowel disease.